Clinical Trial: A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Essential Hypertension
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy in Comparison With Fimasartan Monotherapy for Essential Hypertension Patients
Brief Summary:
The objective of this clinical trial is to evaluate the efficacy and safety of BR1015 Combination therapy group in comparison with Fimasartan monotherapy group at Week 8 for essential hypertension patients who do not adequately responded by Fimasartan 30 mg
Read more